Phoenix Bioscience Core has announced the bioscience startups that make up the second cohort of its XLR8 PBC program.
- AI.VALI (Toronto): Med‑tech SaaS delivering AI‑driven, real‑time endoscopy image analysis and reporting to streamline clinical workflows.
- Hexoskin (Montréal): Smart wearable garments that continuously monitor ECG, respiratory, activity, and sleep via clinically validated sensor‑embedded shirts.
- Paxauris (Phoenix): Inflatable, ergonomic hearing protection (earplugs and hearables) designed for comfort and performance in diverse, high‑noise environments.
- ReSuture (Phoenix): Advanced, AI‑enhanced vascular models and online platforms to elevate surgical training and reduce patient and system risk.
- NeuroCatch (British Columbia): A portable EEG‑based platform to rapidly and objectively assess cognitive brain function via “brain vital signs” at the point‑of‑care.
The selected companies represent cutting-edge advancements in medical technology, addressing critical gaps in AI, wearable garments, hearing protection, and brain functions, and are set to amplify the already thriving Phoenix ecosystem, according to a Phoenix Bioscience Core release. The program has been designed to support founders/CEOs with access to top industry leaders, mentorship, and strategic resources.